To define the critical inflammatory signals that can be used as putative biomarker to follow the progression of cisplatin-AKI, we performed a Pearson correlation between the chemokines identified in our “Inflammation” module and the established biomarker for early kidney injury, NGAL (Lcn2), at Day 3. This evidence concerns the gene LCN2 and acute kidney injury.